These results indicate that vanadate stimulates the particulate PDE3 activity by activating mainly p44 MAPK via a PKA-dependent process, and that it differs from insulin with regard to a phosphorylation cascade of PDE3 activation.
Orthovanadate (vanadate) mimicks most of the biological effects of insulin on isolated rat fat pads or cells. These actions include the stimulation of glucose uptake, 1) the activation of glycogen synthase via an increased tyrosyl phosphorylation of insulin receptor, 2) the inhibition of lipolysis, 3, 4) and an increase in lipoprotein lipase activity. 5) In addition, vanadate has adrenergic actions such as the stimulation of adenylyl cyclase activity in various membranes isolated from rat adipocytes, 6) rat adrenal glands, 7) and rabbit ocular ciliary processes. 8) Actually, the vanadate-stimulated release of lipoprotein lipase and hepatic lipase activities was due to a transient increase in the intracellular cAMP content accompanied by an activation of cAMP-dependent protein kinase (PKA). 9, 10) An increase in the cellular lipoprotein lipase activity by vanadate also was induced through mechanisms differed from the action of insulin. 11) We have recently reported that the incubation of isolated mouse fat pads with vanadate, in contrast to insulin, decreases cellular leptin content and secretion due to increased degradation via a cAMP/PKAdependent process involving proteasome activation and/or ubiquitination. 12, 13) Classically, in rat hepatocytes, vanadate inactivates glycogen synthase and activates glycogen phosphorylase.
14) Cellular levels of cAMP or cGMP are regulated by the relative activities of their synthesizing enzymes, adenylyl cyclase and guanylyl cyclase, and hydrolyzing enzymes, cyclic nucleotide phosphodiesterases (PDEs). PDEs regulate many physiological functions, including cardiac contractility, smooth muscle relaxation, platelet aggregation, visual response, fluid homeostasis, and immune responses. [15] [16] [17] PDE activities are stimulated by a phosphorylation event, the binding of Ca 2ϩ /calmodulin, or the interaction of regulatory proteins. PDEs are classified into 11 or more major isoenzyme families. The particulate PDE from rat adipocytes was stimulated by insulin, 18, 19) and the stimulation of PDE3 was dependent on the activation of Akt but not mitogen-activated protein kinase (MAPK). [20] [21] [22] We previously reported that vanadate stimulated the particulate PDE 3 activity of rat fat pads through the activation of myelin basic protein kinase. 23, 24) The dense vesicle and peripheral plasma membrane PDEs from hepatocytes have been reported to be hormone-sensitive enzymes. 25, 26) The insulin-induced activations of these two PDEs were thought to be achieved by distinct routes. 27, 28) However, the effects of vanadate on the regulation of the hepatic PDEs through receptor signaling pathways are still unknown. It would be of great advantage to clarifying the cellular events which regulate the PDE activity if we knew the intracellular effects of vanadate on hepatocytes.
This paper presents results showing that vanadate stimulates hepatic PDE3 activity via a phosphorylation cascade different from the action of insulin.
MATERIALS AND METHODS

Animals
Male Wistar rats, weighing 250-300 g, were purchased from Shimizu Laboratory Animal Supplies (Kyoto, Japan). They were fed on a commercial pellet diet ad libitum, given free access to water for 1 week according to the Guide for the Care Cell Incubation and Preparation of Subcellular Fractions Hepatocytes were prepared from the liver of 24-h starved rats using collagenase, essentially according to the method of Berry and Friend. 29) The stock solution of vanadate (100 mM, pH 7.4) was diluted with deionized water to the desired concentrations immediately before use. Cells (4ϫ10 6 /ml), which were finally suspended in 10 ml of KrebsRinger bicarbonate buffer, pH 7.4, containing 5 mM glucose and 1% bovine serum albumin (KRBGA), were incubated with vanadate or insulin by shaking at 37°C for the desired periods.
24) The incubated cells were homogenized with a microhomogenizer (NS-310E, Nichion Medical Science, Tokyo, Japan) in 1 ml of chilled 10 mM Tris-HCl buffer, containing 250 mM sucrose, 10 mM sodium pyrophosphate, 1 mM bennzamidine, and 0.1 mM p-amidino-phenylmethanesulfonyl fluoride (p-APMSF). The homogenate was centrifuged at 650 g for 5 min to remove nuclei and again at 10000 g for 20 min to separate the fraction containing the plasma membrane and mitochondoria. The supernatant was further centrifuged at 105000 g for 60 min to separate the particulate and cytosolic fractions. 25, 30, 31) Fractions were prepared without any solubilization procedure and stored at Ϫ80°C. The protein concentration was measured using a Bio-Rad Protein Assay Kit.
PDE Assays Aliquots (50 ml) of fractions (500 mg protein/ml) were incubated with 125 nM [ 3 H]cAMP in 33 mM Tris-HCl buffer, pH 7.4, containing 4 mM MgCl 2 at 30°C for 20 min, in a total volume of 0.25 ml, as described previously. 19, 24) The 5Ј-[ Protein Kinase Assays The cytosolic fraction which had been separated from cells treated with insulin or vanadate was used for protein kinase assays. The MAPK activity was determined using a p42/p44 MAP kinase enzyme assay system, according to the manufacturer's instructions (Amersham Pharmacia Biotech). Briefly, a mixture of 15 ml of the cytosolic fraction (500 mg protein/ml), 10 ml of substrate buffer, pH 7.4, containing substrate peptide, and 5 ml of Mg/ATP buffer reagent, pH 7.4, containing Hepes and [g-32 P]ATP was incubated at 30°C for 30 min. The reaction was terminated by the addition of 10 ml of stop reagent containing orthophosphoric acid and carmosine red, and the reaction mixture was centrifuged at 10000 g for 15 s to wash all reagents into the base of the tube. An aliquot of 30 ml was spotted on to binding paper and washed repeatedly, and the radioactivity was measured. The results were expressed in terms of pmol phosphate/min/mg protein. The Akt activity was determined by a slight modification of the method of Wijkander et al. 22, 32) Briefly, a mixture of an equivalent volume (10 ml) of the cytosolic fraction (500 mg protein/ml) and 11.3 mM Hepes buffer, pH 7.5, containing 130 mM sucrose, 26.6 mM MgCl 2 , 3.3 mM dithiothreitol, 10 mM H-89, 75 mM [g- 32 P]ATP, and 3 mg of peptide RPRAATF as substrate was incubated at 30°C for 20 min. Incubation was terminated by the addition of 15 ml of 1 mM ATP, pH 3.0, containing 1% bovine serum albumin, and 7.5 ml of 30% trichloroacetic acid. After centrifugation at 10000 g for 15 s, 35 ml of the resultant supernatant was applied to phosphocellulose filter paper (Whatman p81) and washed repeatedly. The radioactivity was then measured. The results were expressed in terms of pmol phosphate/min/mg protein. The PKA activity was determined using a PKA Assay Kit, according to the manufacturer's directions (Upstate Biotechnology). Briefly, a mixture of the cytosolic fraction (5 mg protein), assay dilution buffer (pH 7.2), cAMP, PKC/CaMK inhibitor cocktail, Mg/ATP, [g-32 P]ATP, and kemptide as substrate was incubated at 30°C for 10 min, in a total volume of 60 ml. A 25 ml aliquot of the reaction mixture was applied to phosphocellulose filter paper (Whatman p81) and washed repeatedly. The radioactivity was measured. The results were expressed in terms of nmol phosphate/min/mg protein.
Phosphatase Assays The cytosolic fraction which had been separated from the cells treated with insulin or vanadate was assayed for the dual specificity protein phosphatases specific for MAPKs, termed MAPK phosphatases (MKPs). 33) MKP activity was determined using MAP(177-189) pT/pY peptide as substrate by a modified version of the Protein Tyrosine Phosphatase 1B Assay according to the manufacturer's instructions (Calbiochem). Aliquots (5 ml) of the cytosolic fraction (100 mg protein/ml) and 5 ml of 75 nM MKP substrate were added to 40 ml of an assay buffer, pH 7.2, containing 50 mM Hepes, 1 mM dithiothreitol, 1 mM EDTA, and 0.05% NP-40, in each well and incubated at 30°C for 30 min. After termination of the reaction by adding 100 ml of a malachite green colorimetric reagent, the reaction mixtures were allowed to develop color for 30 min. Amounts of phosphate released were measured as absorbance at 620 nm on a microtiter-plate reader. MKP activity was expressed as nmol phosphate released per min per mg protein.
Purification of PDE3, MAPK, and Akt PDE3 was purified partially by chromatography on a DEAE-Sephacel col-umn, essentially according to the method of Ueki et al. 24) The particulate fraction (10 mg protein) was lysed in 1 ml of 0.5% Triton X-100, containing 0.04% 2-mercaptoethanol, 1 mM benzamidine, and 0.1 mM p-APMSF at 4°C for 1 h and centrifuged at 10000 g for 10 min. The resultant supernatant (1 ml) was applied to a DEAE-Sephacel column (7.5 ml) previously equilibrated with 10 mM Tris-HCl buffer, pH 7.0, containing 30 mM 2-mercaptoethanol, 0.1 mM EDTA, 10% glycerol, 1 mM benzamidine, and 0.1 mM p-APMSF (column buffer). The column was washed with the column buffer and eluted stepwise with 0.2-0.4 M NaCl in the column buffer. MAPK and Akt were purified using an antibody column, which had been prepared by immobilization of antibody to CNBr-activated Sepharose 4B. The cytosolic fraction containing 0.04% 2-mercaptoethanol, 1 mM benzamidine, and 0.1 mM p-APMSF was applied to the column (5 ml) previously equilibrated with the column buffer. MAPK was eluted from an anti-MAPK IgG column with a column buffer, pH 11, containing 0.1 M Na 2 CO 3 buffer instead of Tris-HCl buffer. Akt was eluted from an anti-Akt IgG column with a column buffer, pH 3, containing 0.1 M glycine-HCl buffer.
SDS-PAGE and Immunoblotting of IRS-1 and MAPKs
To prepare the IRS-1 sample, hepatocytes (2ϫ10 6 cells) were incubated with insulin or vanadate at 37°C for 10 min in 5 ml of KRBGA, washed with 10 mM Tris-HCl buffer, pH 7.4, containing 250 mM sucrose, and lysed in a solubilizing buffer, pH 7.4, containing 20 mM Tris, 1% Triton X-100, 150 mM NaCl, 50 mM NaF, 10% glycerol, one fifth of a Protease inhibitor cocktail tablet, 1 mM EGTA, 1 mM vanadate, and 1 mM phenylmethanesulfonyl fluoride at 4°C for 30 min. 34) After centrifugation at 10000 g for 10 min, the supernatant was incubated with anti-IRS-1 IgG at 4°C overnight and then with Protein A-Sepharose CL-4B for 2 h. 35) Immunoprecipitates were collected by centrifugation, washed twice with 10 mM phosphate buffer, pH 7.2, containing 150 mM NaCl, 50 mM NaF, and 1 mM vanadate, and subjected to SDS-PAGE on 7.5% slab gels. 36) Immunoblotting procedures were carried out, essentially according to the method of Towbin et al. 37) Briefly, proteins in the gels were transferred electrophoretically to polyvinylidene difluoride membranes. Membranes were blocked and probed with an anti-phosphotyrosine IgG. Blots were then incubated with a goat anti-rabbit IgG coupled to horseradish peroxidase and subjected to chemiluminescence detection, according to the manufacturer's instructions (Amersham Pharmacia Biotech). Band intensities were estimated using an ATTO Densitograph Software Library Lane Analyzer Ver. 2 (ATTO, Tokyo, Japan). 12) For immunoblot analysis of the phosphorylation of MAPKs, hepatocytes were preincubated with or without 50 mM PD98059 for 15 min and further incubated with 100 mM vanadate for 15 or 30 min. The cytosolic fraction was subjected to SDS-PAGE with 8% slab gels and then immunoblotting using anti-MAPK antibody that recognizes either the p42 or p44 isoform of MAPK, as described previously. 24, 37) Statistical Analysis Results are presented as the meanϮS.E. from four separate experiments, each performed in duplicate. The data were analyzed with unpaired Student's t-, Dunnet's, or Bonferroni tests.
RESULTS
Effects of Vanadate and Insulin on PDE Activities in Hepatocytes
We initially investigated which fractions contain PDE isoforms sensitive to vanadate. A 60-min incubation of hepatocytes with vanadate resulted in a predominant increase in PDE activity of the particulate fraction in a dosedependent manner, as compared with that of the fraction containing plasma membrane and mitochondria or the cytosolic fraction (Fig. 1) . When the hepatocytes were incubated with 100 mM vanadate or 10 nM insulin for up to 60 min, a timedependent increase in the particulate PDE activity was observed with vanadate, while insulin increased it significantly at 15 and 30 min (Fig. 2) . Treatment of the particulate fraction with PDE inhibitors revealed a potent effect on the PDE activity by milrinone, a selective inhibitor of PDE3, 38) and weak effect by Ro-20-1724 and rolipram, selective inhibitors of PDE4 39) (Fig. 3) . The IC 50 values were 1.5 for milrinone and 600 mM or more for Ro-20-1724 and rolipram. Thus, the Hepatocytes were incubated with vanadate at the indicated concentrations in 10 ml of KRBGA for 60 min. After the cells were homogenized and fractionated, the fraction containing the plasma membrane and mitochodoria (P1), particulate fraction (P2), and cytosolic fraction were assayed for PDE activities using [
3 H]cAMP as substrate. Results are expressed as a percentage of the un-treated group (control). Significant differences compared with the control: * pϽ0.05 and * * pϽ0.01.
Fig. 2. Time-Dependent Effect of Vanadate or Insulin on PDE Activity in Hepatocytes
Hepatocytes were incubated with 100 mM vanadate or 10 nM insulin or in KRBGA alone for up to 60 min. The particulate PDE activity was determined. Results are expressed as a percentage of each initial value. Significant differences compared with the control at each time point: * pϽ0.05 and * * pϽ0.01.
particulate fraction contained mainly PDE3 sensitive to vanadate and insulin.
Effects of Various Inhibitors on Stimulation of PDE3 Activity by Vanadate or Insulin
The vanadate-induced stimulation of PDE3 activity was inhibited by propranolol, a non-specific adrenergic receptor antagonist, 40) genistein, an inhibitor of receptor tyrosine kinases of growth factors, 41) H-89, a potent inhibitor of PKA, 42) or PD98059, a specific inhibitor of MAPK kinase (MAPKK), 43) to various extent (Table 1) . Wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase (PI3K), 44, 45) did not show any inhibition of the action of vanadate. The results suggest that a MAPKK pathway via PKA is involved in the mechanism of the vanadate action. On the other hand, the insulin-induced stimulation of PDE3 activity was inhibited by genistein or wortmannin but not propranolol, H-89, and PD98059, suggesting that insulin exerts its action in a PI3K-dependent manner. Vanadate may differ from insulin with regard to the mechanism by which it stimulates PDE3 activity.
Phosphorylation Cascade Involved in Action of Vanadate or Insulin To confirm whether or not a signal pathway via the insulin receptor is involved in the stimulation of PDE3 activity by vanadate, the phosphorylation of IRS-1 in hepatocytes was examined. A 10-min incubation of hepatocytes with 10 nM insulin resulted in a 165%-increase in the amount of phosphorylated IRS-1 compared to the control group (Table 2 ). In contrast, no increase in the phosphorylation was observed with 100 mM vanadate, suggesting that the stimulation of PDE3 activity by vanadate is independent of a signaling pathway via the insulin receptor. The PKA activity in hepatocytes treated with 100 mM vanadate reached the maximum at a 15-min incubation and returned to the control level after 45 min (Fig. 4) . A partial inhibition of the effect of vanadate on PKA activity was observed with propranolol or genistein ( Table 3 ). The results suggest that processes utilizing the b-adrenergic receptors and receptor tyrosine kinases of growth factors are involved in the mechanism of the vanadate action. The MAPK activity was increased by vanadate over a 60-min incubation period, while a transient increase by insulin returned to the control level after 30 min (Fig. 5) . The effect of vanadate was markedly inhibited by H-89 or PD98059, suggesting that it is mediated by PKA and MAPKK activations upstream of MAPK (Table 4) . On the other hand, a significant increase in the Akt activity was observed with insulin but not vanadate (Fig. 6) . The insulin-induced increase in the Akt activity was markedly inhibited by wortmannin, suggesting that the Akt activation via PI3K is involved in the insulin action (Table 5) . 792 Vol. 27, No. 6
Fig. 3. Effects of PDE Inhibitors on Particulate PDE Activity
The particulate fraction (500 mg protein/ml) was preincubated with PDE inhibitors at the indicated concentrations in 0.1 ml of the PDE assay buffer for 15 min and then assayed for PDE activity. Results are expressed as a percentage of each group without inhibitors (control). 
Purification of PDE3, MAPK, and Akt
The highest PDE3 activity, 140 pmol/min/mg, was found in fraction nos 49 and 50 which were eluted with a column buffer containing 0.4 M NaCl from a DEAE-Sephacel column (Fig. 7A) . Neither MAPK nor Akt activity was found in the PDE3 fractions. Fraction no. 28, which was eluted from an anti-MAPK IgG column, contained the highest MAPK activity, 325 pmol/min/mg (Fig. 7B) . The highest Akt activity, 19 pmol/min/mg, was found in fraction no. 29, which was eluted from an anti-Akt IgG column (Fig. 7C) . No PDE3 activity was detected in the MAPK and Akt fractions.
Effect of MAPK or Akt on Isolated PDE3 Activity When a partially purified PDE3 was incubated with the MAPK or Akt in the presence of 1 mM ATP, MAPK as well as Akt increased the PDE3 activity in an added dose-dependent manner (Fig. 8) . These results show that MAPK also stimulates the PDE3 activity upstream of PDE3.
Immunoblot Analysis of Phosphorylated MAPKs The phosphorylation of MAPK was assessed by immunoblotting with antibodies which specifically detect either the p42 or p44 isoform of MAPK. The cytosolic fraction contained a major protein of 44 kDa and a minor one of 42 kDa, which are the p44 and p42 isoforms of MAPK, respectively (Figs.  9A and B) . A 15 or 30-min treatment of hepatocytes with vanadate resulted in a retardation of p44 MAPK mobility, probably due to the increased phosphorylation. Almost half of the phosphorylated p44 MAPK returned to the basal level in the presence of PD98059, suggesting that the increased phosphorylation of p44 MAPK is induced via MAPKK.
Effect of Insulin or Vanadate on MKP Activity When hepatocytes were incubated with 100 mM vanadate or 10 nM insulin for up to 60 min, a significant increase in the cytosolic MKP activity was observed with insulin at 15 and 30-min Hepatocytes were preincubated with wortmannin in KRBGA for 15 min at the indicated concentrations and further incubated with or without 10 nM insulin for 30 min for assay of Akt activity. Significant differences compared with the insulin-treated group without inhibitor: * pϽ0.05 and * * pϽ0.01.
Fig. 5. Effect of Vanadate or Insulin on Cytosolic MAPK Activity in Hepatocytes
Hepatocytes were incubated with 100 mM vanadate or 10 nM insulin or in KRBGA alone for up to 60 min. The cytosolic fraction separated was assayed for MAPK activity. Significant differences compared with the control at each time point: * pϽ0.05 and * * pϽ0.01.
Fig. 6. Effect of Vanadate or Insulin on Cytosolic Akt Activity in Hepatocytes
Hepatocytes were incubated with 100 mM vanadate or 10 nM insulin or in KRBGA alone for up to 60 min. The cytosolic fraction was assayed for Akt activity. Significant differences compared with the control at each time point: * pϽ0.05 and * * pϽ0.01.
incubations (Fig. 10) . Vanadate did not increase the cytosolic MKP activity. A 15-min incubation of an activated MAPK (Sigma Chemical) with the cytosolic fraction containing the increased MKP activity resulted in a significant decrease in the MAPK activity (data not shown). A rapid activation of MKP may lead to the inactivation of MAPK by dephosphorylation. 794 Vol. 27, No. 6 
DISCUSSION
Two PDE3 isoforms, PDE3A and PDE3B, are known to be products of different but related genes. 46, 47) PDE3A is highly expressed in cardiac muscle, vascular and visceral smooth muscles, and platelets where it regulates contractility and aggregation, while PDE3B is abundant in adipocytes, hepatocytes, spermatocytes, and renal collecting duct epithelium being involved in hormonal regulation of lipolysis and glycogenolysis.
48) The liver dense vesicle and peripheral plasma membrane PDEs have been reported to be PDE3 and PDE4, respectively, both of which are sensitive to insulin. 47, 49) The dense vesicle PDE3 is associated with the particulate fraction similar to a classical marker enzyme for endoplasmic reticulum.
28) It is also strongly inhibited by cGMP or milrinone. 47, 50) The particulate fraction used throughout this investigation appears to mainly contain PDE3, probably type B, which is stimulated by insulin and vanadate, as suggested by the potent inhibition by milrinone but not rolipram or Ro 20-1724. In adipocytes, the insulin-induced activation of PDE3B was due to Akt-mediated phosphorylation of the enzyme at serine-273 in a PI3K-dependent manner. 51, 52) Akt, also termed protein kinase B, is a serine/threonine kinase and activated by insulin, growth factors, and cytokines to act as a mediator of cell survival and anti-apoptotic signaling. [53] [54] [55] Our results with hepatocytes showed that 100 mM vanadate did not induce the activation of Akt although insulin activated Akt in a PI3K-dependent manner. A partially purified PDE3 activity was increased by addition of MAPK or Akt to the reaction mixture, suggesting MAPK as well as Akt acts upstream of PDE3. IRS-1 proteins undergo tyrosine phosphorylation immediately after insulin stimulation and mediate insulin receptor tyrosine kinase signaling such as binding of PI3K and the associated activation of PDE3B. 56, 57) Treatment of CHO cells over-expressing the human insulin receptor with vanadate caused increased phosphorylation of the p42 and p44 isoforms of MAPK but not the insulin receptor b-subunit or IRS-1 even at 1 mM. 58) Treatment of hepatocytes with vanadate also stimulated both PDE3 and MAPK activities without the increased phosphorylation of IRS-1. Thus, vanadate differed from insulin with regard to the phosphorylation cascade of PDE3. The vanadate-induced activations of PDE3 and MAPK were inhibited by either H-89 or PD98059 but not wortmannin. These results suggest that vanadate stimulates the MAPK activity via a PKA-dependent process leading to the PDE3 activation. MAPKs, also termed extracellular signal-regulated kinases, are serine/threonine kinases and found to be activated in response to insulin and growth factors which promote cell growth and differentiation. 59) Phosphorylation of some proteins including MAPK causes a retardation of their mobility in SDS-PAGE gels. 60) Therefore, the appearance of slower migration forms of phosphorylated MAPK seems to represent the activation of enzyme. Treatment of preadipocytes with agents which increase the intracellular level of cAMP induced phosphorylation/activation of the p42 and p44 isoforms of MAPK via MAPKK.
60) The phosphorylation/activation of p42 MAPK was inhibited by PD 098059 or H-89, suggesting that PKA causes the activation of a MAPK pathway upstream of MAPKK. In hepatocytes in which the p44 isoform of MAPK is mainly detected, vanadate induced a retardation of p44 MAPK mobility, probably due to the increased phosphorylation. In the presence of PD98059, almost half of the phosphorylated p44 MAPK returned to the basal level, suggesting that vanadate stimulates the phosphorylation of p44 MAPK via MAPKK. The adenylyl cyclase activity is stimulated by either extracellular or intracellular stimuli to produce cAMP leading to the PKA activation. Our previous report showed that the vanadate-induced decrease in intracellular leptin of isolated mouse fat pads was prevented by propranolol or bupranolol, a b 3 -adrenergic receptor antagonist, 61) suggesting that a process utilizing the b 3 -adrenergic recptor is involved in mechanisms of the action of vanadate. 12) On the other hand, vanadate stimulated a tyrosine kinase-dependent enhancement of adenylyl cyclase function in human and rat aortic vascular smooth muscle cells, human lymphocytes, and human aortic endothelial cells. 62) The activation of adenylyl cyclase isoform 6 expressed in HEK 293 cells also was mediated by the receptor tyrosine kinase activation with growth factors and vanadate. 63) In response to vanadate, an increase in serine, but not tyrosine, phosphorylation of adenylyl cyclase isoform 6 was observed. The increased serine phosphorylation was suggested to be due to the activation of a serine/threonine kinase, raf-1 kinase, sensitive to receptor tyrosine kinase. Thus, the tyrosine kinase-mediated pathway also may be seen as a regulator of adenylyl cyclase function. The vanadate-induced stimulation of PKA activity in hepatocytes was inhibited in part by propranolol or genistein, suggesting that vanadate may exert its actions via dual signaling pathways of the badrenergic receptors and receptor tyrosine kinases of growth factors. MAPKs are inactivated via dephosphorylation of either the threonine or tyrosine residue or both by MKPs. 64) In vascular smooth muscle cells, insulin results in a small transient effect on MAPK activity and a rapid return to the basal levels within 30 min. 65) A rapid decrease in the insulin-stimulated MAPK activity seemed to be mediated in part by the induction of MKP-1 via the NO/cGMP signaling pathway. 66, 67) Treatment of hepatocytes with insulin also resulted in increased MKP activity in the cytosolic fraction. The incubation of activated MAPK with the fraction containing the increased MKP activity led to a decrease in the MAPK activity by dephosphorylation. Vanadate did not affect the MKP activity although it is well known as a potent inhibitor of protein tyrosine phosphatases. 68) This may be a reason why the stimulation of PDE3 by insulin is independent of a MAPK pathway. Thus, vanadate appears to be a useful biological tool for studying the regulation of PDEs through a receptor signaling pathway.
In conclusion, the results of this study indicate that vanadate stimulates hepatic PDE3 activity by activating mainly p44 MAPK via a PKA-dependent process, and that it differs from insulin with regard to the phosphorylation cascade of PDE3.
